ZACTIMA (an Anti-EGFR / Anti-VEGF Agent) Combined With Docetaxel Compared to Docetaxel in Non-small Cell Lung Cancer
Clinical trial NCT00312377 · COMPLETED
Trial details
- NCT number
- NCT00312377
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2008-08-01
- Enrollment
- 1690
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.